OTC · Financial Statements
Nemaura Medical Inc. (NMRD) Financial Statements
$0.00
OTC: NMRD
Market Cap $4035
Overview Financials Dividend Nemaura Medical Inc. most recently reported annual revenue of $0, net profit of $-14.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2019 2020 2021 2022 2023 Revenue $0 $0 $0 $1.0M $0 Operating Profit $-4.0M $-5.0M $-5.0M $-8.0M $-10.0M Net Profit $-4.0M $-4.0M $-6.0M $-14.0M $-14.0M EPS $-0.25 $-0.20 $-0.28 $-0.59 $-0.57 Op Margin — — — -1502.3% -12454.2%
Balance Sheet (USD)
Metric 2019 2020 2021 2022 2023 Total Assets $5.0M $1.0M $35.0M $22.0M $15.0M Total Liabilities $3.0M $3.0M $27.0M $22.0M $26.0M Cash $4.0M $0 $32.0M $18.0M $10.0M Borrowings $0 $0 $25.0M $19.0M $20.0M
Cash Flow (USD)
Metric 2019 2020 2021 2022 2023 Operating Cash Flow $-4.0M $-3.0M $-6.0M $-7.0M $-8.0M Investing Cash Flow $9.0M $0 $-2.0M $-2.0M $-1.0M Financing Cash Flow $0 $0 $-2.0M $3.0M $-1.0M Net Cash Flow $3.0M $-4.0M $32.0M $-14.0M $-8.0M Free Cash Flow $-4.0M $-4.0M $-7.0M $-7.0M $-9.0M
Valuation & Return Ratios
Metric Value PEG Ratio 0.00 EV / EBITDA -1.36 FCF Yield -222825.23% Quick Ratio 0.53 Interest Coverage -1.50 Return 1Y -50.00% Return 3Y -99.99% Return 5Y —
Screens featuring this stock